Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical

Journal of Nuclear Medicine

Volumn 39, Issue 9, 1998, Pages 1579-1585

  Mathias, Carla J ^a   Wang, Susan ^a   Waters, David J ^a   Turek, John J ^a   Low, Philip S ^a   Green, Mark A ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Folate receptor; Indium 111 diethylenetriamine pentaacetic acid folate; Tumor targeting

Indexed keywords

CITRIC ACID IN 111; FOLIC ACID; PENTETATE FOLIC ACID IN 111; PENTETATE INDIUM IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; CARRIER PROTEINS; FEASIBILITY STUDIES; FOLIC ACID; HUMANS; INDIUM RADIOISOTOPES; KB CELLS; KIDNEY TUBULES, PROXIMAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION;

EID: 0031658693     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rettig W, Garin-Chesa P, Beresford H, Oettgen H, Melamed M, Old L. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci USA 1988;85:3110-3114.
2. Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res 1991;51:5329-5338.
3. Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 1991;51:6125-6132.
4. Stein R, Goldenberg DM, Mattes J. Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest. Int J Cancer 1991;47:163-169.
5. Weitman SD, Lark RU, Coney LR, et al. Distribution of the folate receptor (GP38) in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-3401.
6. Garin-Chesa P, Campbell I, Saigo P, Lewis J, Old L, Rettig W. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol 1993;142:557-567.
7. Holm J, Hansen SI, Sondergaard K, Hoier-Madsen M. The high affinity folate binding protein in normal and malignant mammary gland tissue. Chem Biol Pteridines Folates 1993:757-760.
8. Franklin WA, Waintrub M, Edwards D, et al. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer 1994; 8(suppl):89-95.
9. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994;73:2432-2443.
10. Li PY, Del Vecchio S, Fonti R, et al. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J Nucl Med 1996;37:665-672.
11. 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconj Chem 1996;7:56-62.
12. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor selective radiopharmaceutical targeting via receptor-mediated endocytosis: evaluation of a gallium-67 labeled deferoxamine-folate conjugate. J Nucl Med 1996;37:1003-1008.
13. Mathias CJ, Wang S, Waters DJ, Low PS, Green MA. Ga-67 and In-111 labeled folate-chelate conjugates for targeting tumor-associated folate binding protein [Abstract]. J Nucl Med 1996;37:347P-348P.
14. Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS, Green MA. Indium-111-DTPA-folate as a radiopharmaceutical for targeting tumor-associated folate-binding protein [Abstract]. J Nucl Med 1997;38:133P-134P.
15. 111In-DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconj Chem 1997;8:673-679.
16. McHugh M, Cheng YC. Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 1979;254:11312-11318.
17. Antony AC, Kane MA, Portillo RM, Elwood PC, Kolhouse JF. Study of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate. J Biol Chem 1985;260:14911-14917.
18. Kutsky RJ. Handbook of vitamins, minerals, and hormones, 2nd ed. New York: Van Nostrand Reinhold; 1981:273.
19. Samuels ML. Statistics for the life sciences. San Francisco: Dellen; 1989:249-256.
20. Selhub J, Franklin WA. The folate-binding protein of rat kidney. J Biol Chem 1984;259:6601-6606.
21. Selhub J, Emmanouel D, Stavropoulos T, Arnold R. Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies. Am J Physiol 1987:252: F750-F756.
22. Selhub J, Nakamura S, Carone FA. Renal folate absorption and the kidney folate binding protein. II. Microinfusion studies. Am J Physiol 1987;252:F757-F760.
23. Williams WM, Huang KC, Renal tubular transport of folic acid and methotrexate in the monkey. Am J Physiol 1982;242:F484-F490.
24. Birn H, Nielsen S, Christensen EI. Internalization and apical-to-basolateral transport of folate in rat kidney proximal tubule. Am J Physiol 1997;272:F70-F78.
25. Crom WR, Evans WE. Methotrexate. In: Evans WE, Schemag JJ, Jusko WJ, Relling MV, eds. Applied pharmacokinetics, 3rd ed. Vancouver, WA: Applied Therapeutics: 1992:29-1-29-42.
26. Miotti S, Canevari S, Menard S, et al. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer 1987;39:297-303.
27. Mezzanzanica D, Garrido MA, Neblock DS, et al. Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab′)2 antibody prolong host survival in a murine xenograft model. Cancer Res 1991;51:5716-5721.
28. Rothenberg SP, daCosta M. Further observations on the folate-binding factor in some leukemic cells. J Clin Invest 1971;50:719-726.
29. Westerhof G R, Jansen G, van Emmerik N, et al. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier-and receptor-mediated transport systems. Cancer Res 1991;51:5507-5513.
30. Kamen BA, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular foiate content. Proc Natl Acad Sci USA 1986;83:5983-5987.
31. Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M. Overexpression of folate binding protein in ovarian cancers. Int J Cancer 1977;74:193-198.
32. DuBeshter B, Lin J, Angel C, Poulter CA. Gynecologic tumors. In: Rubin P, ed. Clinical oncology, 7th ed. Philadelphia: WB Saunders; 1993:363-418.